Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet

World J Gastroenterol. 2014 Jun 7;20(21):6680-4. doi: 10.3748/wjg.v20.i21.6680.


In the present study we report on changes in irritable bowel syndrome-severity scoring system (IBS-SSS) and irritable bowel syndrome-quality of life (IBS-QoL) in 19 IBS patients, aged 18 to 74 years (F/M: 14/5), during 12 wk registering their symptoms on the web-application ( During a control period of the first 6-wk patients were asked to register their IBS-SSS and IBS-QoL on the web-application weekly without receiving any intervention. Thereafter, low fermentable oligo-, di-, mono-saccharides and polyols (FODMAP) diet (LFD) was introduced for the next 6 wk while continuing the registration. Though a small sample size a significant improvement in disease activity (IBS-SSS) was observed during both the control period, median: 278 (range: 122-377), P = 0.02, and subsequently during the LFD period, median: 151 (range: 29-334), P < 0.01. The IBS-QoL solely changed significantly during the LFD period, median: 67 (37-120), P < 0.01. The significant reduction in disease activity during the control period shows a positive effect of the web-application on IBS symptoms when presented as a "traffic light". However adding the diet reduced IBS-SSS to < 150, inactive to mild symptoms. In the future results from larger scale trials are awaited.

Keywords: Disease activity; Disease-specific quality of life; Irritable bowel syndrome; Low fermentable oligo-, di-, mono-saccharides and polyols diet; Self-management.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Diet*
  • Disaccharides / administration & dosage
  • Female
  • Fermentation
  • Humans
  • Internet
  • Irritable Bowel Syndrome / diet therapy*
  • Irritable Bowel Syndrome / physiopathology*
  • Male
  • Middle Aged
  • Monosaccharides / administration & dosage
  • Oligosaccharides / administration & dosage*
  • Polymers / administration & dosage
  • Quality of Life
  • Remission Induction
  • Telemedicine*
  • User-Computer Interface
  • Young Adult


  • Disaccharides
  • Monosaccharides
  • Oligosaccharides
  • Polymers
  • polyol